Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

hexal a/s - pemetrexeddinatrium 2,5-hydrat - koncentrat til infusionsvæske, opløsning - 25 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

ever valinject gmbh - pemetrexeddinatrium 2,5-hydrat - koncentrat til infusionsvæske, opløsning - 25 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

zentiva k.s. - pemetrexeddinatrium 2,5-hydrat - infusionsvæske, opløsning - 10 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

aurobindo pharma (malta) limited - pemetrexeddinatrium 2,5-hydrat - pulver til koncentrat til infusionsvæske, opløsning - 1000 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

aurobindo pharma (malta) limited - pemetrexeddinatrium 2,5-hydrat - pulver til koncentrat til infusionsvæske, opløsning - 100 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

aurobindo pharma (malta) limited - pemetrexeddinatrium 2,5-hydrat - pulver til koncentrat til infusionsvæske, opløsning - 500 mg

Den Europæiske Union - dansk - EMA (European Medicines Agency)

baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastiske midler - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

viatris limited - pemetrexed - koncentrat til infusionsvæske, opløsning - 25 mg/ml